# Cordis acquires MedAlliance for up to $1.135 billion

Cordis announced the acquisition of MedAlliance, a Swiss developer of drug-eluting balloons. The deal includes an initial $35M investment, $200M payment upon closing in 2023, and up to $900M in regulatory and commercial milestones through 2029.

- Type: Acquisition
- Announced: 2022-10-17
- Where: Switzerland
- Value: $1.14B
- Status: announced
- Products: SELUTION SLR drug-eluting balloon
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cordis](https://endata.com/companies/48117.md) (acquirer)
- [MedAlliance](https://endata.com/companies/48118.md) (target)

## Sources

- [cordis.com](https://cordis.com/na/news/new-press-release), 2022-10-17: "The acquisition of MedAlliance illustrates our vision to maximize patient impact by pairing highly innovative growth drivers with Cordis’ trusted brand and extensive global commercial capabilities."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.